Search Within

Guilherme Harada

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (6)
  2. GME, Medicine (6)
  3. Graduate Medical Education (6)
  4. Sloan Kettering Institute Postdocs (6)
  5. Solid Tumor Oncology Division (6)
  6. Thoracic Oncology (6)

More Groups

People
  1. Alexander Drilon (6)
  2. Matteo Repetto (3)
  3. Soo Ryum Yang (2)
  4. Yonina Murciano-Goroff (2)
  5. Zsofia Stadler (2)
  6. Alison Schram (1)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. British Journal of Cancer (1)
  3. JCO Precision Oncology (1)
  4. The Oncologist (1)
  5. npj Precision Oncology (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Nature Publishing Group (1)
  3. Oxford University Press (1)
  4. Springer Nature (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
    Journal Article

    Nykaza, I.; Murciano-Goroff, Y. R.; Desilets, A.; Harada, G.; Postow, M. A.; Callahan, M. K.; Lee, C. H.; Rudin, C. M.; Kelsen, D. P.; Stadler, Z. K.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • BRAF variants and oncogenic fusions to define sporadic MMR-deficient colorectal cancer subtypes
    Meeting Abstract

    Abdelfattah, S.; Harada, G.; Patel, S.; Artz, O.; Yaeger, R.; Johannet, P.; Harrold, E.; Walch, H. S.; Argiles, G.; Rousseau, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents
    Journal Article

    Roa, P.; Foglizzo, V.; Harada, G.; Repetto, M.; Kulick, A.; de Stanchina, E.; de Marchena, M.; Auwardt, S.; Sayed Ahmed, S.; Bremer, N. V.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers
    Journal Article

    Thawani, R.; Repetto, M.; Keddy, C.; Nicholson, K.; Jones, K.; Nusser, K.; Beach, C. Z.; Harada, G.; Drilon, A.; Davare, M. A.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Amplification of wild-type RET represents a novel molecular subtype of several cancer types with clinical response to selpercatinib
    Journal Article

    Gandhi, M. M.; Ricciuti, B.; Harada, G.; Repetto, M.; Gildenberg, M. S.; Singh, A.; Li, Y. Y.; Gagné, A.; Wang, X.; Aizer, A.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to TRK inhibitors
    Meeting Abstract

    Harada, G.; Choudhury, N. J.; Schram, A. M.; Rosen, E.; Murciano-Goroff, Y. R.; Falcon, C. J.; Wilhelm, C.; Kaplanis, L. A.; Liu, D.; Chang, J. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save